Robert O. Dillman is a medical oncologist and hematologist, Clinical Professor of Medicine at the University of California Irvine, and the Chief Medical Officer for AIVITA Biomedical, Inc. in Irvine, California. He has a bachelor’s degree from Stanford University, a medical degree from Baylor College of Medicine, and completed internal medicine training at Baylor, and hematology/oncology fellowship training at the University of California San Diego. He was the Hoag Cancer Center Medical Director in Newport Beach, California, for 25 years, is a founding member of and past president of the Society for the Immunotherapy of Cancer (SITC), and was Chairman of the Cancer Biotherapy Research Group. His clinical research career has focused on biotherapy, especially monoclonal antibodies, and immunotherapy, autologous cellular therapies, and personal cancer vaccines.